Explain this page
Arphra AIPlain-English read on Molson Coors Beverage Company’s valuationRatios & metrics
Profitability, returns on capital, growth, and credit — all derived from the historical income statement, balance sheet, and cash flow rows in our data warehouse.
Valuation multiples
Price- and EV-based multiples plus shareholder yields. Snapshot at each fiscal year-end from key_metrics (FMP).
ActualEstimate
| In USD | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | 2026E | 2027E | 2028E | 2029E |
|---|---|---|---|---|---|---|---|---|---|
| Headline | |||||||||
| Market cap | — | — | — | — | — | — | — | — | — |
| Enterprise value | — | — | — | — | — | — | — | — | — |
| Multiples | |||||||||
| P / E | — | — | — | — | — | — | — | — | — |
| P / B | — | — | — | — | — | — | — | — | — |
| EV / EBITDA | — | — | — | — | — | — | — | — | — |
| EV / Sales | — | — | — | — | — | — | — | — | — |
| EV / FCF | — | — | — | — | — | — | — | — | — |
| Yields | |||||||||
| Earnings yield | — | — | — | — | — | — | — | — | — |
| Free cash flow yield | — | — | — | — | — | — | — | — | — |
| Dividend yield | — | — | — | — | — | — | — | — | — |
Profitability
Margin structure across the last 5 fiscal years
ActualEstimate
| In USD | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | 2026E | 2027E | 2028E | 2029E |
|---|---|---|---|---|---|---|---|---|---|
| Margins | |||||||||
| Gross margin | +39.43% | +34.16% | +37.33% | +38.99% | +37.58% | +38.74% | +37.29% | +38.73% | +38.62% |
| Operating margin | +14.15% | +1.47% | +12.29% | +15.08% | -21.01% | +2.14% | +2.07% | +2.10% | +2.14% |
| EBITDA margin | +22.23% | +8.16% | +18.54% | +21.89% | -14.46% | +8.85% | +8.81% | +8.59% | +8.74% |
| EBIT margin | +14.59% | +1.76% | +12.70% | +15.36% | -20.94% | +2.36% | +2.36% | +2.33% | +2.39% |
| Pre-tax margin | +12.05% | -0.58% | +10.70% | +12.93% | -22.60% | +0.33% | +0.34% | +0.34% | +0.35% |
| Net margin | +9.78% | -1.64% | +8.11% | +9.65% | -19.21% | -0.48% | -0.47% | -0.49% | -0.49% |
| Cost structure | |||||||||
| Cost of revenue / sales | +60.57% | +65.84% | +62.67% | +61.01% | +62.42% | +61.69% | +63.43% | +62.62% | +60.39% |
| R&D intensity | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| SG&A intensity | +24.85% | +24.47% | +23.76% | +21.64% | +23.27% | +23.46% | +22.80% | +22.99% | +23.31% |
| Effective tax rate | +18.60% | — | +23.64% | +22.97% | — | +23.51% | +23.13% | +23.08% | +22.57% |
Returns on capital
ROE / ROA / ROC / ROIC over the relevant capital base, plus the 3-step DuPont decomposition of ROE.
ActualEstimate
| In USD | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | 2026E | 2027E | 2028E | 2029E |
|---|---|---|---|---|---|---|---|---|---|
| Returns | |||||||||
| Return on equity (ROE) | +7.36% | -1.36% | +7.06% | +8.34% | -20.29% | -0.45% | -0.43% | -0.46% | -0.45% |
| Return on assets (ROA) | +3.64% | -0.68% | +3.60% | +4.31% | -9.41% | -0.22% | -0.22% | -0.23% | -0.22% |
| Return on capital (ROC) | +6.97% | +0.81% | +7.30% | +8.92% | -13.90% | +1.33% | +1.25% | +1.30% | +1.30% |
| Return on invested capital (ROIC) | +4.82% | +0.61% | +4.82% | +5.71% | -10.42% | +1.00% | +0.94% | +0.98% | +0.98% |
| Asset turnover | +37.22% | +41.37% | +44.37% | +44.61% | +49.00% | +45.43% | +46.74% | +45.70% | +45.87% |
| DuPont · ROE decomposition | |||||||||
| Net margin | +9.78% | -1.64% | +8.11% | +9.65% | -19.21% | -0.48% | -0.47% | -0.49% | -0.49% |
| Asset turnover (× revenue / assets) | +37.22% | +41.37% | +44.37% | +44.61% | +49.00% | +45.43% | +46.74% | +45.70% | +45.87% |
| Equity multiplier (× assets / equity) | +202.13% | +200.29% | +196.31% | +193.75% | +215.68% | +205.87% | +194.23% | +204.35% | +200.31% |
Activity & efficiency
Turnover ratios and days-outstanding — how efficiently the business converts assets and working capital into sales and cash.
ActualEstimate
| In USD | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | 2026E | 2027E | 2028E | 2029E |
|---|---|---|---|---|---|---|---|---|---|
| Turnover | |||||||||
| Asset turnover | 0.37 | 0.41 | 0.44 | 0.45 | 0.49 | 0.45 | 0.47 | 0.46 | 0.46 |
| Fixed-asset turnover | 2.45 | 2.53 | 2.63 | 2.61 | 2.34 | — | — | — | — |
| Inventory turnover | 7.74 | 8.89 | 9.14 | 9.75 | 9.71 | — | — | — | — |
| Receivables turnover | 11.69 | 12.35 | 13.31 | 13.79 | 15.85 | — | — | — | — |
| Payables turnover | 2.97 | 3.41 | 3.70 | 3.78 | 3.82 | — | — | — | — |
| Days outstanding | |||||||||
| Days sales outstanding (DSO) | 31.22 | 29.55 | 27.43 | 26.46 | 23.03 | — | — | — | — |
| Days inventory outstanding (DIO) | 47.17 | 41.08 | 39.93 | 37.45 | 37.57 | — | — | — | — |
| Days payables outstanding (DPO) | 123.00 | 107.14 | 98.59 | 96.48 | 95.67 | — | — | — | — |
| Cash conversion cycle | -44.60 | -36.52 | -31.23 | -32.57 | -35.06 | — | — | — | — |
Cash flow quality
How well reported earnings translate into operating and free cash flow, plus reinvestment intensity.
ActualEstimate
| In USD | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | 2026E | 2027E | 2028E | 2029E |
|---|---|---|---|---|---|---|---|---|---|
| Operating CF / Net income | 1.56 | -8.57 | 2.19 | 1.70 | -0.83 | -35.29 | -35.18 | -33.86 | -34.12 |
| FCF / Net income | 1.04 | -4.80 | 1.48 | 1.10 | -0.50 | -22.87 | -23.00 | -21.41 | -22.30 |
| FCF margin | +10.22% | +7.86% | +12.03% | +10.63% | +9.58% | +10.92% | +10.88% | +10.56% | +10.92% |
| OCF margin | +15.31% | +14.04% | +17.77% | +16.43% | +16.02% | +16.85% | +16.64% | +16.69% | +16.71% |
| CapEx / Revenue | +5.08% | +6.18% | +5.74% | +5.80% | +6.43% | +5.86% | +6.13% | +5.88% | +5.96% |
| CapEx / D&A | 0.66 | 0.97 | 0.98 | 0.89 | 1.01 | — | — | — | — |
| Stock-based comp / Revenue | +0.31% | +0.31% | +0.38% | +0.37% | +0.31% | — | — | — | — |
Per-share & shareholder yield
EPS, book value, sales, cash flow and dividends per share — plus payout / retention.
ActualEstimate
| In USD | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | 2026E | 2027E | 2028E | 2029E |
|---|---|---|---|---|---|---|---|---|---|
| EPS · diluted | 4.62 | -0.86 | 4.37 | 5.35 | -10.85 | 4.74 | 4.98 | 5.40 | 5.93 |
| EPS · basic | 4.63 | -0.86 | 4.39 | 5.38 | -10.83 | 4.74 | 4.94 | 5.35 | 5.92 |
| Book value / share | 62.79 | 59.54 | 61.83 | 64.09 | 53.87 | 60.42 | 62.73 | 61.68 | 62.91 |
| Tangible BV / share | -26.54 | -23.87 | -20.73 | -20.60 | -17.34 | 60.42 | 62.73 | 61.68 | 62.91 |
| Sales / share | 47.24 | 49.34 | 53.85 | 55.39 | 56.93 | 56.52 | 56.95 | 57.60 | 57.81 |
| Operating CF / share | 7.23 | 6.92 | 9.57 | 9.10 | 9.12 | 9.52 | 9.48 | 9.62 | 9.66 |
| Free cash flow / share | 4.83 | 3.88 | 6.48 | 5.89 | 5.46 | 6.17 | 6.20 | 6.08 | 6.31 |
| Dividends / share | 0.68 | 1.52 | 1.63 | 1.76 | 1.92 | 1.86 | 1.86 | 1.81 | 1.80 |
| Payout ratio | +14.70% | -187.85% | +37.38% | +32.89% | -17.59% | -688.11% | -689.00% | -636.86% | -634.41% |
| Retention ratio | +85.30% | +287.85% | +62.62% | +67.11% | +117.59% | +788.11% | +789.00% | +736.86% | +734.41% |
Growth
Year-over-year change for headline P&L lines, plus through-cycle CAGR
ActualEstimate
| In USD | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | 2026E | 2027E | 2028E | 2029E | 8y CAGR |
|---|---|---|---|---|---|---|---|---|---|---|
| Top-line | ||||||||||
| Revenue · YoY | — | +4.10% | +9.36% | -0.64% | -4.18% | -0.05% | +0.33% | +0.60% | +0.01% | +1.12% |
| Gross profit · YoY | — | -9.82% | +19.52% | +3.77% | -7.65% | +3.05% | -3.41% | +4.49% | -0.30% | +0.86% |
| Profit | ||||||||||
| Operating income · YoY | — | -89.17% | +813.14% | +21.90% | -233.52% | +110.17% | -2.67% | +1.83% | +1.83% | -20.16% |
| EBITDA · YoY | — | -61.81% | +148.52% | +17.32% | -163.29% | +161.15% | -0.10% | -1.91% | +1.73% | -10.02% |
| Net income · YoY | — | -117.43% | +641.30% | +18.28% | -290.63% | +97.52% | +0.56% | -4.83% | +0.63% | — |
| Operating | ||||||||||
| EBIT · YoY | — | -87.45% | +690.27% | +20.13% | -230.63% | +111.26% | +0.37% | -0.50% | +2.41% | -19.34% |
| R&D · YoY | — | — | — | — | — | — | — | — | — | — |
| Per-share | ||||||||||
| EPS · diluted · YoY | — | -118.61% | +608.14% | +22.43% | -302.80% | +143.66% | +5.12% | +8.52% | +9.65% | +3.16% |
| EPS · basic · YoY | — | -118.57% | +610.47% | +22.55% | -301.30% | +143.76% | +4.15% | +8.41% | +10.72% | +3.13% |
Credit & leverage
Balance-sheet health + interest coverage + liquidity. Coverage ratios use period-end debt and trailing interest expense.
ActualEstimate
| In USD | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | 2026E | 2027E | 2028E | 2029E |
|---|---|---|---|---|---|---|---|---|---|
| Leverage | |||||||||
| Total debt | $7.21B | $6.61B | $6.27B | $6.19B | $6.3B | $6.02B | $6.24B | $6.09B | $6.18B |
| Net debt | $6.57B | $6.01B | $5.4B | $5.22B | $5.4B | $5.13B | $5.33B | $5.17B | $5.27B |
| Net debt / EBITDA | 2.87 | 6.88 | 2.49 | 2.05 | -3.35 | 5.21 | 5.41 | 5.36 | 5.37 |
| Debt / equity | 0.53 | 0.51 | 0.47 | 0.46 | 0.60 | 0.51 | 0.51 | 0.51 | 0.51 |
| Debt / assets | +26.10% | +25.54% | +23.78% | +23.76% | +27.70% | +24.55% | +26.11% | +24.75% | +25.24% |
| Equity / assets | +49.47% | +49.93% | +50.94% | +51.61% | +46.37% | +48.57% | +51.48% | +48.94% | +49.92% |
| Coverage | |||||||||
| EBITDA / interest expense | 8.74 | 3.69 | 9.48 | 9.11 | -7.14 | 4.09 | 4.13 | 3.93 | 4.14 |
| Operating income / interest | 5.56 | 0.67 | 6.29 | 6.28 | -10.38 | 0.99 | 0.97 | 0.96 | 1.01 |
| Interest expense | $261.6M | $236.3M | $228.8M | $279.3M | $225.6M | $240.89M | $238M | $245.48M | $237.12M |
| Liquidity | |||||||||
| Current ratio | 0.77 | 0.78 | 0.70 | 0.94 | 0.55 | — | — | — | — |
| Quick ratio | 0.42 | 0.43 | 0.43 | 0.60 | 0.30 | — | — | — | — |
| Cash ratio | 0.18 | 0.18 | 0.21 | 0.32 | 0.17 | — | — | — | — |
| Working capital | -$843.5M | -$737.4M | -$1.24B | -$196.8M | -$2.38B | — | — | — | — |
| Working capital / revenue | -8.21% | -6.89% | -10.63% | -1.69% | -21.32% | — | — | — | — |
Methodology. ROE / ROA / ROC use period-end balance-sheet denominators (no average-of- period smoothing). ROIC = Operating Income × (1 − inferred effective tax rate) over invested capital, with the effective tax inferred from net-to-operating income when both are positive and a 25% default otherwise. Net debt / EBITDA, debt ratios, and interest-coverage ratios are calculated point-in-time at each fiscal year-end. TTM = trailing 4 quarters (income / cash flow summed, balance sheet = most-recent quarterly snapshot). Through-cycle CAGR in the Growth panel uses the geometric mean of first-to-last period growth across the window (positive values only).